NOTV Inotiv Corporation Total Debt to Capital

The price action of Inotiv, Inc. (NOTV), where the total debt-to-equity ratio stands at 0.00, confirms the impact of high demand for toxicological testing. Inotiv, Inc. (NOTV) generates revenue from laboratory analyses for global biotech behemoths, assisting them in the regulatory approval of new drugs. However, the international network of centers is exposed to risks stemming from trade restrictions and raw material supply chain issues from Asia.

This indicator measures financial leverage by comparing total liabilities to net assets to assess the business's degree of dependence on borrowed capital. By analyzing the debt-to-equity ratio, an investor determines the resilience of Inotiv, Inc. (NOTV) to rising interest rates when financing costly ESG standards and sustainable waste disposal systems in preclinical research.